Bronconex Acticap

Страна: Новая Зеландия

Язык: английский

Источник: Medsafe (Medicines Safety Authority)

Активный ингредиент:

Mometasone furoate 400ug (anhydrous)

Доступна с:

Organon (New Zealand) Limited

ИНН (Международная Имя):

Mometasone furoate 400 µg (anhydrous)

дозировка:

400 mcg/dose

Фармацевтическая форма:

Powder for inhalation

состав:

Active: Mometasone furoate 400ug (anhydrous) Excipient: Lactose

Штук в упаковке:

Inhaler, metered, DPI, (sample), 14 dose units

класс:

Prescription

Тип рецепта:

Prescription

Производитель:

MSD International GmbH (Singapore Branch)

Терапевтические показания :

Bronconex Acticap is indicated for prophylactic therapy in the management of patients with asthma of all severities, including patients who have been dependent upon either inhaled or systemically administered corticosteroids and non-corticosteroid-dependent patients inadequately controlled on other drug regimens.

Обзор продуктов:

Package - Contents - Shelf Life: Inhaler, metered, DPI, (sample) - 14 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 30 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 60 dose units - 18 months from date of manufacture stored at or below 25°C

Дата Авторизация:

2000-12-05